All thyroid cancers are not 'created equal'— avoiding unnecessary or 'excessive' treatment

July 25, 2018, The Dartmouth Institute for Health Policy & Clinical Practice

More Americans are being diagnosed with thyroid cancer than ever before—over the past 25 years its incidence has tripled. This year alone, more than 50,000 people in the U.S., the majority of them of women, will receive a thyroid cancer diagnosis. Yet, despite the dramatic rise in the rate of diagnosis, morality due to thyroid cancer has remained stable.

In an upcoming article in the New England Journal of Medicine, Drs. H. Gilbert Welch (The Dartmouth Institute for Health Policy and Clinical Practice) and Gerard Doherty (Dept. of Surgery, Brigham and Women's Hospital), assert that this steep increase in the number of people being diagnosed with —largely reflecting the detection of small papillary cancers—points to widespread overdiagnosis. Efforts to reduce overdiagnosis are needed, such as refraining from biopsying small thyroid nodules as advocated by the American Thyroid Association. But, Welch and Doherty also advocate strongly for measures designed to reduce overtreatment. These include:

  • Active surveillance for selected with small papillary thyroid cancers
  • In cases where patients prefer to remove the , Welch and Doherty state the case for a thyroid lobectomy (removal of about half the ), the lesser of the two surgical options available, as opposed to a total thyroidectomy. The less-extensive lobectomy carries a lower risk of nerve damage, avoids the risk of hypoparathyroidism and, in many cases, allows patients to forgo the need for permanent thyroid hormone-replacement.

The risk of death from thyroid cancer is extremely low (roughly 2% over 25) years and that risk is unaffected by the choice of procedure—total thyroidectomy or lobectomy. Given that fact, one would expect that lobectomy would be the more common surgical procedure of the two. Surprisingly, as Welch and Doherty point out, the opposite is true: The rate of total thyroidectomy is increasing, with about 80% of patients who have surgery to treat localized thyroid cancer undergoing a full thyroidectomy.

While speculating on the reasons for this apparent contradiction—lack of knowledge of new practice guidelines, the difficulties associated with "de-intensifying" care—Welch and Doherty suggest primary care practitioners can help by educating patients about the heterogeneity of cancer: not all cancers or cancer diagnosis are the same- some cancers warrant aggressive treatment, some less aggressive treatment, others are better off left alone

"The average age of diagnosis for thyroid cancer is 50, as compared to say the average of breast cancer which is 62," Welch says. "So, potentially someone could live up to half of their life with the effects—both physical and psychological—of these treatments. That's something we need to take very seriously."

Explore further: Thyroidectomy rates lower after guideline implementation

Related Stories

Thyroidectomy rates lower after guideline implementation

April 2, 2018
(HealthDay)—Implementation of the 2015 American Thyroid Association guidelines on surgery for well-differentiated thyroid carcinoma was associated with a significant decrease in the rates of both up-front total thyroidectomy ...

Male thyroid cancer survivors face 50 percent higher risk of heart disease than women

May 29, 2018
Male thyroid cancer survivors have a nearly 50 percent higher risk of developing heart disease than women within five years of cancer diagnosis, according to a new study published in the Endocrine Society's Journal of Clinical ...

Removal of lobe instead of total thyroid may benefit papillary thyroid cancer patients

October 19, 2016
Most Americans with thyroid cancer have an operation to remove the thyroid gland, but those with a smaller, less-threatening form of thyroid cancer may be missing out on a less extensive, less costly, and safer operation ...

Thyroid cancer cases soar; is it overdiagnosed?

February 22, 2014
A dramatic rise in thyroid cancer has resulted from overdiagnosis and treatment of tumors too small to ever cause harm, according to a study that found cases nearly tripled since 1975.

Thyroid tumors in Alaska natives are larger and more advanced at diagnosis

April 11, 2018
A new study spanning 45 years has shown that while Alaska Natives have a similar incidence of thyroid cancer as the U.S. white population, their tumors at the time of diagnosis tend to be larger and to have spread beyond ...

Insurance expansion associated with increase in surgical treatment of thyroid cancer

April 5, 2017
The 2006 Massachusetts health reform, a model for the Affordable Care Act, was associated with significant increases in surgical intervention for thyroid cancer, specifically among nonwhite populations, according to a study ...

Recommended for you

Some brain tumors may respond to immunotherapy, new study suggests

December 10, 2018
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis ...

Study finds higher risk of breast cancer for women after giving birth

December 10, 2018
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children, according to a large-scale analysis co-led by a University of North Carolina Lineberger ...

A code for reprogramming immune sentinels

December 10, 2018
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

Researchers develop personalized medicine tool for inherited colorectal cancer syndrome

December 10, 2018
An international team of researchers led by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes ...

Study shows key enzyme linked to therapy resistance in deadly lung cancer

December 10, 2018
Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small ...

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.